Still, the Ozempic manufacturer's stock has already suffered from the tariff news — and with its months-long downward value trajectory, the company can't really afford to lose any more money. The ...

Shares of Novo Nordisk (NYSE: NVO) are falling this week, down 33% as of 3:27 p.m. ET on Friday. The drop comes as the S&P ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.